Lisbon, Portugal

Eunice Costa


 

Average Co-Inventor Count = 3.3

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Eunice Costa: Innovator in Pharmaceutical Formulations

Introduction

Eunice Costa is a notable inventor based in Lisbon, Portugal. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of inhalable medications. With a total of 3 patents to her name, her work focuses on innovative solutions for treating respiratory conditions.

Latest Patents

One of her latest patents is for the use of inhaled ivermectin. This invention contemplates the application of inhaled ivermectin for various viruses and parasitic infections that manifest in the lungs or respiratory tract. The patent also discloses exemplary dosing, formulations, devices, and processing techniques. Another significant patent is a method of production of inhalable composite particles using a three-fluid nozzle. This method involves preparing a pharmaceutical formulation suitable for inhalation by simultaneously drying solutions in a spray dryer equipped with a three-fluid nozzle to produce particles containing an active agent and an excipient.

Career Highlights

Eunice has worked with reputable companies in the pharmaceutical industry, including Hovione Scientia Limited and Cipla Limited. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking innovations in inhalable medications.

Collaborations

Eunice has collaborated with several professionals in her field, including Filipe Neves and Claudia Moura. These collaborations have further enhanced her research and development efforts in pharmaceutical formulations.

Conclusion

Eunice Costa is a pioneering inventor whose work in inhalable medications has the potential to transform treatment options for respiratory infections. Her innovative patents and collaborations reflect her commitment to advancing pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…